» Articles » PMID: 36139534

MicroRNA-769-3p Acts As a Prognostic Factor in Oral Squamous Cell Cancer by Modulating Stromal Genes

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Sep 23
PMID 36139534
Authors
Affiliations
Soon will be listed here.
Abstract

miR-769-3p expression is suppressed in the stromal subtype of head and neck squamous cell carcinoma (HNSCC); however, its role in stromal HNSCC has not been fully elucidated. To investigate the biological relevance of miR-769-3p in the stromal phenotype, we established oral squamous cell cancer (OSCC) cell lines, namely CAL27, HSC3, and YD8, overexpressing miR-769-3p. miR-769-3p expression was positively and negatively correlated with interferon-gamma-related genes and MYC target gene sets, respectively. miR-769-3p decreased OSCC cell migration and invasion as well as mesenchymal marker expression and increased epithelial marker expression. Moreover, miR-769-3p enhanced OSCC cell sensitivity to 5-fluorouracil. High miR-769-3p expression was associated with good prognosis of HNSCC patients. Collectively, these results suggest that miR-769-3p suppression enhances stromal gene expression and promotes the epithelial-to-mesenchymal transition. Therefore, miR-769-3p may be a potential biomarker of the miRNA phenotype in OSCC patients.

Citing Articles

miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR.

Cao D, Wu Z, Yang R, Yao L, Huang J, Ding Y J Cancer. 2024; 15(11):3338-3349.

PMID: 38817860 PMC: 11134426. DOI: 10.7150/jca.93595.


miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology.

Kozlowska-Maslon J, Guglas K, Kolenda T, Lamperska K, Makalowska I Rep Pract Oncol Radiother. 2024; 28(5):681-697.

PMID: 38179293 PMC: 10764040. DOI: 10.5603/rpor.96666.

References
1.
Luo E, Chang Y, Sher Y, Huang W, Chuang L, Chiu Y . MicroRNA-769-3p down-regulates NDRG1 and enhances apoptosis in MCF-7 cells during reoxygenation. Sci Rep. 2014; 4:5908. PMC: 4118187. DOI: 10.1038/srep05908. View

2.
. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

3.
Berezikov E, Cuppen E, Plasterk R . Approaches to microRNA discovery. Nat Genet. 2006; 38 Suppl:S2-7. DOI: 10.1038/ng1794. View

4.
Wang K, Yang S, Gao Y, Zhang C, Sui Q . MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway. Oncol Lett. 2020; 19(1):992-1000. PMC: 6924179. DOI: 10.3892/ol.2019.11135. View

5.
Holt J, Walter V, Yin X, Marron D, Wilkerson M, Choi H . Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2020; 27(3):831-842. PMC: 7854517. DOI: 10.1158/1078-0432.CCR-20-0557. View